Viewing nowCombinationSubira Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 201404048 · Approved 2014.08.29
Treatment of ulcers and acid-related disorders (including gastritis and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used to treat ulcers of the stomach and duodenum. It is also effective for gastritis and gastroesophageal reflux disease, and helps with conditions associated with excess gastric acid secretion, such as Zollinger-Ellison syndrome. It can be given before anesthesia to prevent Mendelson's syndrome and is also used to prevent the occurrence of ulcers after surgery. It is suitable for treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). By treating various gastrointestinal diseases, it helps alleviate symptoms and aids in treatment.
○ Adults Usually, administer 2 tablets orally per dose, 2 times daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose, 2 times daily, or 4 tablets per dose, once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose, 2 times daily, in the morning and at bedtime. The same dosage applies to concomitant therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing time may occasionally be prolonged depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets per dose, 2 times daily, or 4 tablets per dose, once daily at bedtime. However, in patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose, 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets per dose, 3 times daily, as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose, 2 times daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets per dose on the night before surgery.
This medication should not be used in patients with poor kidney function or those undergoing dialysis. Patients who have had allergic reactions to this medication or its ingredients should not take it. Caution is advised for patients with a history of rare blood disorders such as acute porphyria, as this medication may trigger seizures. Patients who have undergone upper gastrointestinal surgery, pregnant women, or those who may become pregnant should avoid taking this medication for safety. It should also be avoided in premature infants and newborns, as well as in patients on a potassium-restricted diet. Patients with liver function issues, a history of drug allergies, elderly patients, or those with previous kidney problems should use this medication carefully. If taking non-steroidal anti-inflammatory drugs concurrently, especially elderly patients or those with a history of peptic ulcers should be regularly monitored. This medication can mask symptoms of gastric cancer, so patients with gastric ulcers or middle-aged patients who have recently developed dyspepsia should confirm there is no malignancy before use. Patients with gastric and duodenal ulcers infected with Helicobacter pylori should undergo treatment to eradicate the bacteria. Caution is required for critically ill patients as gastric stones may develop. The aluminum content of this medication may interfere with phosphate absorption, so patients with hypophosphatemia should also use it cautiously. Patients who have difficulty swallowing should be careful as respiratory complications may arise. While taking this medication, there is a rare possibility of severe allergic reactions such as anaphylactic shock, so if symptoms appear, discontinue use immediately and notify healthcare professionals. Hypersensitivity reactions such as skin rashes, urticaria, angioedema, fever, bronchospasm, hypotension, and chest pain may occur, and should prompt discontinuation of the medication. There is a rare possibility of decreased white blood cells or platelets on blood tests, so if symptoms such as systemic fatigue, bleeding, or fever occur, consult healthcare professionals immediately. Liver function abnormalities may occur, so if symptoms of jaundice or hepatitis appear, stop taking the medication and seek medical attention. Elders or patients with a history of heart disease should exercise caution as abnormalities in heart rhythm have been reported rarely. Digestive symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and while stool color may change, no special treatment is usually needed. Neuropsychiatric symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, and headaches may occur rarely, and any abnormal symptoms should be reported to healthcare professionals. Rare symptoms such as gynecomastia, increased milk secretion, erectile dysfunction, and decreased libido have been reported, although direct correlation with this medication is not certain. Muscle aches or joint pain may appear rarely, and if signs of severe muscle damage occur, stop taking the medication immediately. Rare skin abnormalities such as rashes or hair loss have been reported; consult healthcare professionals if skin changes occur. It is advisable not to take this medication for a prolonged period, and during treatment, periodic blood, liver, and kidney function tests should be performed to check for abnormalities. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems may have an increased risk of pneumonia while taking this medication, so caution is advised. Dizziness or drowsiness may occur after taking this medication, so it is safer to avoid driving or operating hazardous machinery. There may be drug interactions, especially with anticoagulants, certain antibiotics, and anticonvulsants, so caution is warranted. It is safest for pregnant women, women who may become pregnant, or breastfeeding women to avoid this medication. Safety and efficacy in children have not been established, so it is advisable not to administer it to minors. In cases of overdose, treatment such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be required to remove the drug. As this medication can reduce gastric acid secretion, promoting bacterial growth in the stomach, regular check-ups including ocular examinations are needed with long-term use.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container that prevents air from entering, at a temperature between 1°C and 30°C. Storing it this way helps maintain its effectiveness.
White round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.